IIM
RLAY icon

INTECH Investment Management’s Relay Therapeutics RLAY Stock Holding History

INTECH Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$638K Buy
34,101
+2,484
+8% +$36.1K 0.01% 1236
2026
Q1 		$315K Sell
31,617
-21,584
-41% -$193K ﹤0.01% 1555
2025
Q4 		$450K Buy
53,201
+14,492
+37% +$103K ﹤0.01% 1563
2025
Q3 		$202K Sell
38,709
-15,534
-29% -$59.2K ﹤0.01% 2063
2025
Q2 		$188K Sell
54,243
-27,185
-33% -$80.9K ﹤0.01% 2116
2025
Q1 		$213K Buy
81,428
+33,783
+71% +$132K ﹤0.01% 2058
2024
Q4 		$196K Buy
47,645
+11,469
+32% +$62.4K ﹤0.01% 2039
2024
Q3 		$256K Buy
+36,176
New +$270K ﹤0.01% 1604

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

INTECH Investment Management's RLAY Position: Q2 2026 in Review

INTECH Investment Management increased its Relay Therapeutics (RLAY) stake by 7.9% in Q2 2026, buying an estimated $36.1K and bringing the position to 34,101 shares worth $638K. The position accounts for 0.01% of the portfolio, ranked #1236.

INTECH Investment Management first reported a position in RLAY in Q3 2024 and has held it in 8 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • INTECH Investment Management held 34,101 shares of Relay Therapeutics worth $638K as of Q2 2026.
  • INTECH Investment Management bought 2,484 Relay Therapeutics shares in Q2 2026, an estimated $36.1K.
  • Relay Therapeutics made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1236 holding.
  • INTECH Investment Management first reported a position in Relay Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.